Results of a cross-sectional study showed former smokers eligible for lung cancer screening should be asked about recent tobacco use and exposure, while counseling about the harms of these 2 risk factors is warranted.
Results of a cross-sectional study of data from the 2013–2018 National Health and Nutrition Examination Survey (NHANES) revealed former smokers eligible for lung cancer screening (LCS) should be asked about recent tobacco use and exposure, while counseling about the harms of these 2 risk factors is warranted.
The findings were published in the Journal of General Internal Medicine.
Updated United States Preventive Services Task Force (USPSTF) recommendations indicate all adults aged 50 to 80 years with a 20 pack-year smoking history, and who currently smoke or have quit within the past 15 years should undergo LCS, authors wrote.
However, “while recommendations are clear for current smokers who present for LCS, the guidelines for counseling former smokers are not well defined,” they added.
In an effort to better understand former smoker behavior and identify high-risk former smokers who would benefit from targeted counseling at the time of LCS, researchers assessed deidentified NHANES data from 472 former smokers eligible for LCS.
All participants had smoked at least 100 cigarettes in their lifetime and did not currently smoke at the time of the survey. Main study outcomes were recent tobacco use and exposure. “Former smokers without recent tobacco use were classified as having recent tobacco exposure if their cotinine levels were greater than 0.05 ng/mL,” researchers explained.
Cotinine is a nicotine metabolite reflecting recent exposure. Any cotinine level above the race/ethnic cut points for tobacco use, or reported tobacco use in the past 5 days constituted “recent tobacco use.”
The majority of former smokers eligible for LCS were non-Hispanic White (82.7%), male (67.1), and had incomes more than 100% over the federal poverty level (83.3%).
Analyses revealed:
The high levels of recent tobacco use and exposure among former smokers eligible for LCS underscore the need for improved assessment and provider counseling, researchers wrote.
“Providers can use this data to inform strategies that improve assessments and target former smokers for counseling on their continued risk for tobacco-related addiction, disease, and mortality, particularly for cardiovascular and respiratory disease,” they said.
Further clarification on guidance for assessing tobacco use may also be helpful to minimize misclassification of current smokers, while asking about any use in the past month may be better at characterizing this patient population.
Environmental interventions may be particularly useful for these patients, authors added. “Patients may be counseled that there is no risk-free level of smoke exposure and advised to make a smoke-free home rule, not just for the continued risk of developing lung cancer but more immediately for cardiovascular health.”
Biomarker based exposure via cotinine levels may also be beneficial to better classify former smokers with secondhand smoke exposure; however, high sensitivity lab tests for cotinine may not be widely available.
“Future studies should assess whether including cotinine levels may change patient behavior and outcomes, and what the cost-effectiveness of this approach might be,” researchers said.
The self-reported nature of current smoking status marks a limitation to the analysis.
Reference
Hood-Medland EA, Dove MS, Tong EK. Assessment and counseling gaps among former smokers eligible for lung cancer screening in US adults. J Gen Intern Med. Published online April 26, 2022. doi:10.1007/s11606-022-07542-0
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Prediction Model Identified Risk Factors for ED Visits in Patients With Lung Cancer
December 7th 2023A risk prediction model that was based on machine learning could help to make resource utilization more efficient by correctly predicting emergency department (ED) visits in patients with lung cancer.
Read More
Trilaciclib May Reduce Hospitalization and Improve Survival in ES-SCLC
November 23rd 2023Patients with extensive-stage small cell lung cancer (ES-SCLC) who receive trilaciclib appear to experience lower rates of hematologic adverse effects than those who are not treated with the agent.
Read More